LQDA, US53635D2027

Liquidia stock gains 5.35 percent to EUR 31.70, 59.60 percent below its 52-week high

Published on 10/15/2026 at 21:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HC Wainwright lifted its target to USD 65.00 on October 15, 2026. Liquidia stock costs EUR 31.70 on October 15, 2026, up 5.35 percent versus the Tradegate close.

Analyst target and trading data

HC Wainwright lifted Liquidia's target from USD 58.00 to USD 65.00 on October 15, 2026.
Liquidia's next earnings date is November 3, 2026.
Liquidia stock costs EUR 31.70 at Lang & Schwarz on October 15, 2026 at 9:43 p.m. CEST, 5.35 percent above the Tradegate close of October 14, 2026.
Liquidia has a P/E ratio of 25.95 and a market capitalization of USD 3.2 billion.

LQDA, US53635D2027, Illustration mit AI erstellt.

An analyst note dated October 15, 2026 said HC Wainwright lifted Liquidia's target from USD 58.00 to USD 65.00, putting the target 83.51 percent above the Nasdaq price of USD 35.42, according to The Stock Observer. At Lang & Schwarz on October 15, 2026 at 9:43 p.m. CEST, Liquidia stock was trading at EUR 31.70, up 5.35 percent versus the Tradegate close of October 14, 2026 at EUR 30.09.

HC Wainwright lifts its target

The analyst action gives Liquidia investors a new USD 65.00 benchmark after the previous USD 58.00 target. The target distance uses the Nasdaq price of USD 35.42 at 3:49 p.m. ET on October 15, 2026, and places the target 83.51 percent above that quote. The same report retained a Buy rating for the stock.

The euro quote is below its high

The German euro quote stood between its dated intraday low of EUR 28.67 and high of EUR 31.86 on October 15, 2026, while the Lang & Schwarz price was EUR 31.70 later in the session. The 52-week euro range was EUR 18.95 to EUR 78.46, leaving the price 59.60 percent below the high. The Nasdaq quote carried a 52-week range of USD 21.94 to USD 93.61.

Valuation and next reporting date

Liquidia's market capitalization was USD 3.2 billion and its P/E ratio was 25.95 on October 15, 2026. The company reported USD 284.2 million in cash at June 30, 2026, while the second-quarter revenue figure was USD 171.68 million, according to the latest quarterly figures carried by The Stock Observer. The next earnings date is November 3, 2026, as listed by JrHisse.

Comparison with peers

LQDA: plus 5.35 percent, P/E 25.95, market capitalization USD 3.2 billion
United Therapeutics (Nasdaq, USD): plus 0.44 percent, P/E 19.41, market capitalization USD 23.3 billion
Gossamer Bio (Nasdaq, USD): minus 1.07 percent, P/E minus 0.16, market capitalization USD 53.8 million.

Trading reference

Liquidia's euro quotation remains well below its 52-week high, while the latest analyst target sits above the same-day Nasdaq price. On Nasdaq, Liquidia's common stock trades under LQDA, as identified by MarketWatch.

Liquidia was trading at EUR 31.70 at Lang & Schwarz on October 15, 2026 at 9:43 p.m. CEST, 5.35 percent above the Tradegate close of October 14, 2026 at EUR 30.09.

The further course of trading is shown by the continuously updated real-time quote of Liquidia stock.